STEPHANIE ALLISON: Open Payments
NPI 1225537871 · HOLLAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,369 in 79 payments from 22 companies in 2025. Trend: 2023 $1,283 · 2024 $915 · 2025 $1,369
Food & beverage: $1,326Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $195 |
| Amgen Inc. | 11 | $167 |
| Ascendis Pharma Endocrinology Inc | 6 | $108 |
| Tandem Diabetes Care, Inc. | 11 | $107 |
| Mannkind Corporation | 4 | $106 |
| Antares Pharma, Inc. | 4 | $90 |
| Lilly USA, LLC | 4 | $64 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $62 |
| Sequel Med Tech, LLC | 3 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
Products named: Ozempic, Yorvipath, t:slim X2 Insulin Pump with Control-IQ, AFREZZA, TEPEZZA, XYOSTED, MOUNJARO, ISTURISA.
Industry payments across OH — which companies pay providers there.
